By Fanny Gillet and edited by Colleen Young
On April Wednesday 3rd, we explored as yet uncharted territory for #hcsmca, namely pharmaceutical companies, their reputation and the role they can or should play in the future of health care. The chat was moderated by @williampearl who also wrote an article on her blog Social Media Pearls, introducing her framing of the topics.
T1: What can pharmaceutical companies do to improve their reputation /relationships in health care?
The first comments pointed to transparency and accountability as key ingredients to improving their reputation. They should, for example, explain where the money goes, why they stop certain drug production or how they target the research funds.
T1 They can ensure needed drugs don’t disappear unexpectedly or for no reason but $ #hcsmca
— Annette McKinnon (@anetto) 3 avril 2013
T1: Show they are invested in positive patient outcomes (not just $)e.g. compassionate…
View original post 698 more words
